221 related articles for article (PubMed ID: 37088403)
1. Engineering cells for precision drug delivery: New advances, clinical translation, and emerging strategies.
Chao CJ; Zhang E; Zhao Z
Adv Drug Deliv Rev; 2023 Jun; 197():114840. PubMed ID: 37088403
[TBL] [Abstract][Full Text] [Related]
2. Myeloid cell-mediated drug delivery: From nanomedicine to cell therapy.
Zhang F; Xu Z; Jolly KJ
Adv Drug Deliv Rev; 2023 Jun; 197():114827. PubMed ID: 37068659
[TBL] [Abstract][Full Text] [Related]
3. In situ cellular hitchhiking of nanoparticles for drug delivery.
Udofa E; Zhao Z
Adv Drug Deliv Rev; 2024 Jan; 204():115143. PubMed ID: 38008185
[TBL] [Abstract][Full Text] [Related]
4. Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery.
Waheed S; Li Z; Zhang F; Chiarini A; Armato U; Wu J
J Nanobiotechnology; 2022 Aug; 20(1):395. PubMed ID: 36045386
[TBL] [Abstract][Full Text] [Related]
5. Red Blood Cell Inspired Strategies for Drug Delivery: Emerging Concepts and New Advances.
Zhang E; Phan P; Algarni HA; Zhao Z
Pharm Res; 2022 Nov; 39(11):2673-2698. PubMed ID: 35794397
[TBL] [Abstract][Full Text] [Related]
6. Engineering the drug carrier biointerface to overcome biological barriers to drug delivery.
Finbloom JA; Sousa F; Stevens MM; Desai TA
Adv Drug Deliv Rev; 2020 Dec; 167():89-108. PubMed ID: 32535139
[TBL] [Abstract][Full Text] [Related]
7. Targeting Strategies for Tissue-Specific Drug Delivery.
Zhao Z; Ukidve A; Kim J; Mitragotri S
Cell; 2020 Apr; 181(1):151-167. PubMed ID: 32243788
[TBL] [Abstract][Full Text] [Related]
8. Cell-based carrier for targeted hitchhiking delivery.
Liu T; Gao C; Gu D; Tang H
Drug Deliv Transl Res; 2022 Nov; 12(11):2634-2648. PubMed ID: 35499717
[TBL] [Abstract][Full Text] [Related]
9. Challenges to macromolecular drug delivery.
Juliano R
Biochem Soc Trans; 2007 Feb; 35(Pt 1):41-3. PubMed ID: 17233596
[TBL] [Abstract][Full Text] [Related]
10. Bioengineered cellular and cell membrane-derived vehicles for actively targeted drug delivery: So near and yet so far.
Thanuja M Y ; Anupama C ; Ranganath SH
Adv Drug Deliv Rev; 2018 Jul; 132():57-80. PubMed ID: 29935987
[TBL] [Abstract][Full Text] [Related]
11. Microfluidics in drug delivery: review of methods and applications.
Rawas-Qalaji M; Cagliani R; Al-Hashimi N; Al-Dabbagh R; Al-Dabbagh A; Hussain Z
Pharm Dev Technol; 2023 Jan; 28(1):61-77. PubMed ID: 36592376
[TBL] [Abstract][Full Text] [Related]
12. Molecular engineering solutions for therapeutic peptide delivery.
Acar H; Ting JM; Srivastava S; LaBelle JL; Tirrell MV
Chem Soc Rev; 2017 Oct; 46(21):6553-6569. PubMed ID: 28902203
[TBL] [Abstract][Full Text] [Related]
13. Engineering nanosystems to overcome barriers to cancer diagnosis and treatment.
Alhaj-Suliman SO; Wafa EI; Salem AK
Adv Drug Deliv Rev; 2022 Oct; 189():114482. PubMed ID: 35944587
[TBL] [Abstract][Full Text] [Related]
14. Methods and Study Designs for Characterizing the Pharmacokinetics and Pharmacodynamics of Carrier-Mediated Agents.
Schorzman AN; Lucas AT; Kagel JR; Zamboni WC
Methods Mol Biol; 2018; 1831():201-228. PubMed ID: 30051434
[TBL] [Abstract][Full Text] [Related]
15. Leveraging Engineering of Cells for Drug Delivery.
Chen Z; Hu Q; Gu Z
Acc Chem Res; 2018 Mar; 51(3):668-677. PubMed ID: 29446615
[TBL] [Abstract][Full Text] [Related]
16. Advances in Drug Delivery Systems Based on Red Blood Cells and Their Membrane-Derived Nanoparticles.
Nguyen PHD; Jayasinghe MK; Le AH; Peng B; Le MTN
ACS Nano; 2023 Mar; 17(6):5187-5210. PubMed ID: 36896898
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in targeted gene silencing and cancer therapy by nanoparticle-based delivery systems.
Liu H; Zhu X; Wei Y; Song C; Wang Y
Biomed Pharmacother; 2023 Jan; 157():114065. PubMed ID: 36481408
[TBL] [Abstract][Full Text] [Related]
18. Engineering precision nanoparticles for drug delivery.
Mitchell MJ; Billingsley MM; Haley RM; Wechsler ME; Peppas NA; Langer R
Nat Rev Drug Discov; 2021 Feb; 20(2):101-124. PubMed ID: 33277608
[TBL] [Abstract][Full Text] [Related]
19. Exploiting homing abilities of cell carriers: Targeted delivery of nanoparticles for cancer therapy.
Tiet P; Berlin JM
Biochem Pharmacol; 2017 Dec; 145():18-26. PubMed ID: 28941937
[TBL] [Abstract][Full Text] [Related]
20. Engineering a Nano/Biointerface for Cell and Organ-Selective Drug Delivery.
Song D; Xu Q
Langmuir; 2022 Aug; 38(30):9092-9098. PubMed ID: 35852946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
